Intrinsic Value of S&P & Nasdaq Contact Us

GH Research PLC GHRS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IE • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$36.50
+114.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

GH Research PLC (GHRS) has a negative trailing P/E of -18.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 101.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -5.29%, forward earnings yield 0.98%.

Criteria proven by this page:

  • VALUE (69/100, Pass) — analyst target implies upside (+114.7%).
  • Forward P/E 101.7 — analysts expect a return to profitability with estimated EPS of $0.17 for FY2030.
  • Trailing Earnings Yield -5.29% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.98% as earnings recover.
  • Analyst consensus target $36.50 (+114.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
49/100
SG Score
View full scorecard →
VALUE
69/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
40/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — GHRS

Valuation Multiples
P/E (TTM)-18.9
Forward P/E101.7
PEG RatioN/A
Forward PEGN/A
P/B Ratio3.26
P/S Ratio0.00
EV/EBITDA-13.2
Per Share Data
EPS (TTM)$-0.78
Forward EPS (Est.)$0.17
Book Value / Share$4.51
Revenue / Share$0.00
FCF / Share$-0.72
Yields & Fair Value
Earnings Yield-5.29%
Forward Earnings Yield0.98%
Dividend Yield0.00%
Analyst Target$36.50 (+114.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -1,738.7 0.00 1,347.50 0.00 -
2020 -1,310.8 -40.42 103.18 0.00 -
2021 -131.9 -0.12 4.38 0.00 -
2022 -22.5 1.01 2.02 0.00 -
2023 -8.5 -0.02 1.38 0.00 -
2024 -9.3 -0.91 2.04 0.00 -
2025 -16.1 -3.01 2.77 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.00 $0.00 $-310K -
2020 $-0.01 $0.00 $-446K -
2021 $-0.18 $0.00 $-9.21M -
2022 $-0.14 $0.00 $-7.14M -
2023 $-0.68 $0.00 $-35.59M -
2024 $-0.75 $0.00 $-38.96M -
2025 $-0.79 $0.00 $-48.26M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.46 $-1.89 – $-1.00 $0.00 $0.00 – $0.00 6
2027 $-1.82 $-2.28 – $-1.35 $50.65M $50.65M – $50.65M 5
2028 $-2.18 $-3.34 – $-1.54 $5.06M $5.06M – $5.06M 7
2029 $-1.60 $-1.60 – $-1.60 $91.25M $91.25M – $91.25M 2
2030 $0.17 $0.17 – $0.17 $345.68M $345.68M – $345.68M 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message